← Eichor
Study identifier: NCT05193227 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Sustained Release Lidocaine for the Treatment of Postoperative Pain

Condition: Postoperative Pain · Postsurgical Pain  ·  Sponsor: University of British Columbia

PhasePhase 2
Planned participants120
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

In this study, the investigators are testing a new formulation of lidocaine for its suitability in managing postoperative pain after pelvic (circumcision, inguinal, scrotal), perineal (hemorrhoidectomy) or perianal (fistulotomy) incisions. The new formulation ST-01 is a sustained release lidocaine formulation and is expected to provide pain relief over multiple days. Currently, the drug lidocaine is not available as an injectable slow-release formulation.

This description comes directly from the study's public registry record.

Talk to the study team

Lesley Parker  ·  604 875 5594  ·  lparker@sustainedtx.com

Graeme Boniface  ·  604-875-5594  ·  gboniface@prostatecentre.com

Always discuss trial participation with your own doctor first.

Locations (2)

Vancouver Prostate CentreVancouver, British Columbia, CanadaRecruiting
St. Pauls HospitalVancouver, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05193227